Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 22.
Published in final edited form as: J Empir Res Hum Res Ethics. 2024 Jan 8;19(1-2):3–15. doi: 10.1177/15562646231222665

“My Blood, You Know, My Biology Being out There…”: Consent and Participant Control of Biological Samples

Susan Racine Passmore 1, Abigail Gerbitz 1, Gregory R Hancock 2, Laura Evans 3, Gina Green-Harris 4,5, Dorothy Farrar Edwards 1,5,6, Tyson Jackson 1, Stephen B Thomas 7,8
PMCID: PMC10957312  NIHMSID: NIHMS1951350  PMID: 38192107

Abstract

The widespread and persistent underrepresentation of groups experiencing health disparities in research involving biospecimens is a barrier to scientific knowledge and advances in health equity. To ensure that all groups have the opportunity to participate in research and feel welcome and safe doing so, we must understand how research studies may be shaped to promote inclusion. In this study, we explored the decision to participate in hypothetical research scenarios among African American adults (n = 169) that varied on the basis of four attributes (form of consent, reason for research, institutional affiliation and race of the researcher). Findings indicate that participants were largely willing to contribute to biobanks but significantly preferred opportunities where they had control over the use of their biological samples through tiered or study-specific forms of consent. Broad consent procedures, although common and perhaps preferred by participants with high trust in researchers, may amount to an exclusionary practice.

Keywords: Inclusive research practices, African American, research participation, biospecimens, genomics, health equity

Introduction

Diversity in research participation is critical to the achievement of health equity, yet studies rarely have adequate participation from the very populations that suffer most from health inequities (Knepper & McLeod, 2018; Oh et al., 2015). This lack of diversity can also potentially result in the exacerbation of health inequities. For example, the promise of precision medicine depends on mapping the human genome, but this information is only as good as participant samples and the Genomic Wide Association Studies (GWAS) Diversity Monitor reports that 95% of total GWAS participants from a total of 6263 studies are of European descent. Other descent groups including Asian (3%), African (.2%), African American or Afro-Caribbean (.5%), Hispanic or Latin American (.3%) and other/mixed descent (.7%) are underrepresented both in term of proportion of the world’s population and the distribution of poor health outcomes (Mills & Rahal, 2020). The cause of the problem of representation in health research is complex and has implications well beyond genomics research. Indeed, a lack of diversity pervades the research enterprise including when the condition under study is a known health disparity (Boden-Albala et al., 2021; Knepper & McLeod, 2018). Causes include distrust of researchers and health professionals as a consequence of historical abuse and current experiences of discrimination in healthcare settings (Corbie-Smith et al., 2002; Passmore et al., 2020b; Quinn et al., 2013), the presence of bias and systemic racism in science and research (Gilmore-Bykovskyi et al., 2021; Griffith et al., 2020), as well as, a lack of rigor and attention to the study of research inclusion (Gilmore-Bykovskyi et al., 2021; Passmore et al., 2020b).

Our focus on the lack of diversity in research participation to date has been largely trained on issues of distrust (Corbie-Smith et al., 2002; Scharff et al., 2010). While accurate and important, this focus on the problem as located in underrepresented communities has not substantially moved us toward solutions and may have, in fact, compounded the problem somewhat (Passmore et al., 2021). There is evidence that investigators feel that distrust amounts to an insurmountable barrier to diversity in research and, ironically, a justification for not pursuing inclusive practices (Niranjan et al., 2019; Passmore et al., 2021). Recent discussions have accurately reframed the issue as a crisis of untrustworthiness in research and call for a more rigorous explorations (Gilmore-Bykovskyi et al., 2021; Griffith et al., 2020; Wilkins, 2018) and a rethinking of how we can minimize the deleterious effects of “exclusionary research practices” (Gilmore-Bykovskyi et al., 2021).

The difference between a focus on distrust or researcher trustworthiness is subtle but critical in our work to increase diversity in research participation. With a focus on distrust, we position the issue within the communities that are underrepresented in research. In contrast, a focus on trustworthiness trains attention onto the obligation of researchers and the research community to create opportunities for participation that are inclusive. Moreover, the work on distrust has tended to emphasize the role of historical research abuse such as the Tuskegee Syphilis Study or the Havasupai case against Arizona State University (N. Garrison, 2013; Reverby, 2010). While such events are absolutely a source of distrust in underrepresented communities and undoubtedly deserving of attention, such an emphasis can led to assumptions that distrust relates exclusively to past contexts. Finally, there have been few explorations of the practical meaning of trust and the components of trustworthiness such as competency and motive, and that could provide meaningful directions forward (Jamison et al., 2019; Passmore et al., 2020b; Twyman et al., 2008).

Authors have argued, more recently, that researchers must overtly re-shape practices to increase accessibility for marginalized potential participants to build trustworthiness (Gilmore-Bykovskyi et al., 2021; Griffith et al., 2020; Wilkins, 2018). In short, they point out that, among other contributing factors, the lack of diversity in all research including those collecting biological specimens, is exacerbated by practices that are convenient for researchers and privilege certain groups of participants over others (Niranjan et al., 2019; Wilkins, 2018). Participants representing historically marginalized groups, in contrast, may require more and different approaches to feel welcome, safe or able to participate in research. Such participants may need materials in a range of languages, more opportunities to ask questions, and greater assurances that they will have access to the benefits of research (Lemke et al., 2012). As health equity requires the participation of more diverse groups of people in research, our job as researchers is to discover the diverse needs, goals and values of the people we hope to study so that we may accommodate them. Indeed, distrust in researchers and science is not so much a barrier as a call to innovation and action.

In this study, our team explored factors that contribute to the decision to participate in genomics research among African Americans adults living in the urban areas of Madison and Milwaukee, Wisconsin. A secondary goal was to test the feasibility of using a new methodology, called the research StoryDeck, to determine the acceptability of study attributes to be used to practically promote diversity in research participation. We asked our participants to assess the acceptability of hypothetical genomic studies that varied on four factors: race of the investigative team, research goal, sponsoring institution and form of consent. Each of these factors is strongly connected to research participation in the literature (Davis et al., 2013; Echeverri et al., 2018; Frierson et al., 2019; Fryer et al., 2015; Guillemin et al., 2018; Levkoff & Sanchez, 2003; Moulton et al., 2020). Our choice of “form of consent” was additionally motivated by previous studies that have indicated that the use of, specifically, broad consent is a barrier to research participation as well as its common use in genomics research (Passmore et al., 2020b). In studies using broad consent, participants sign a single consent form at the time of enrollment in one study, which also confers their consent for future, perhaps yet to be determined, studies. By offering broad consent, future scientists are free to use collected biospecimens to support many and varied health advances without having to burden additional participants or re-contact existing participants each time a new study is initiated. Yet, there is much evidence that broad form of consent is not acceptable or as acceptable with historically marginalized communities in comparison to their white counterparts (D’Abramo et al., 2015; Fatumo et al., 2022; N. A. Garrison et al., 2016). Participants most comfortable with or who prefer broad consent have been shown to be White, affluent, older, highly educated, and those with “high trust” in researchers (Trinidad et al., 2010). Others may favor tiered consent, in which participants are able to set parameters during the initial consent process on the use of their genetic materials (i.e., only for use in studies on a specific condition or by a specific institution, etc.,) or dynamic consent in which the use of interactive digital platforms afford participants the ability to be notified of study opportunities and monitor how their data are used (Fatumo et al., 2022; Nembaware et al., 2019; Petrini, 2010).

Methods

In order to determine how our factors (race of the investigative team, institution, form of consent, research goal) figured into participant decision making, we used the research StoryDeck, a card sort elicitation technique matched with a factorial survey design used to create research scenarios for participant review (Passmore et al., 2020a; Passmore et al., 2020b). This method produces both quantitative and qualitative data simultaneously to determine patterns in the acceptability of research scenarios as well as the process and meaning driving choices about acceptability. The StoryDeck also provides insight on the interaction of factors revealing the relative “weight” of barriers and facilitators to determine, among other things, how barriers may become acceptable in combination with facilitating attributes. To accommodate remote data collection, a virtual StoryDeck survey was developed and distributed to most interested participants to complete on their own (n = 131). An additional subset (n = 38) was created by offering an administrated version of the survey with a “think aloud” interview (Padilla & Leighton, 2017; Priede & Farrall, 2011) to every fourth interested participant. Adults (18 years of age and older) who self-identified as African Americans living in areas around Madison and Milwaukee were eligible to participate.

Following from Green, a sample size of n = 140 participants each viewing eight scenarios was determined to be necessary for the planned general linear models (Green, 1991). Given the sensitivity of a prior study to detect interactions among the categories of attributes using classification and regression tree (CART) analysis (Passmore et al., 2020b), the increased sample size planned provided even greater statistical power to glean the attributes’ confluence in respondents’ hypothetical study participation. Our decision to use eight scenarios for each participant was informed by two conflicting considerations. Initially, the number of observations (data) is substantially increased with each additional reviewed scenario increasing our confidence in the CART analysis. With eight scenarios and a sample 140, there are 1,120 total, randomly selected, reviewed scenarios. However, there are only so many scenarios a participant can view before they become fatigued and, even, irritated. Our decision to use eight scenarios represents a compromise between these two concerns informed by previous experience.

The University of Wisconsin – Madison Survey Center developed the infrastructure for a mobile based administration of the survey using “virtual” cards representing a range of research study attributes (form of consent, diversity of the research team, research goal, and institutional affiliation) that was optimized for mobile and other devices. As noted, participants were presented with eight research “opportunities” or scenarios. Each scenario involved a genomics research study (uses DNA to explore genetic connections to disease) that varied on a set of attributes (presented in Table 1). Each participant saw eight scenarios with random assignment of the 4 factors x 3 characteristics. As such, all participants saw individually generated scenarios varying on the constellation of characteristics. However, no participants were presented with the same constellation of characteristics more than once.

Table 1.

Attribute Categories and Characteristics for Research Scenarios.

Attribute Categories Form of Consent Reason for Research Institution Race of the researcher

Characteristic 1 Your DNA will be destroyed after use in this study (study specific consent) To find a cure for a disease that impacts a family member or close friend University of Wisconsin-Madison 1 African American PI/1 White PI (Diverse team)
Characteristic 2 Your DNA will be used for other studies but only if you agree for each study (tiered consent) To find a cure for a disease that impacts AAs more than other groups US Government 2 White PIs (Disconcordant)
Characteristic 3 Used by other in other studies by other teams for different goals without you knowing (broad consent) To find a cure for a disease that impacts all people equally Medical College of Wisconsin 2 African American PIs (Concordant)

Scenarios were presented using virtual cards, randomly selected in each category, which could be “flipped” by the participant with a click. Once all the study characteristics of a particular scenario were revealed, participants were able to respond to the item “How likely are you to participate in this study?” (See Figure 1). Participants were also asked to respond to demographic questions including race, ethnicity, income, education, age and gender. Race and ethnicity questions followed the format used in the United States 2020 census (Marks & Jones, 2020).

Figure 1.

Figure 1.

Screen shot of online story deck instrument.

Two groups (n = 18) of African American adults living in Madison and Milwaukee, identified with the help of community partners, reviewed the instrument prior to data collection. Reviewing participants made suggestions on language and format, which were adopted in the final instrument. Pilot testing with these groups revealed an average completion time of seven minutes of the survey alone.

Given public health restrictions at the time, participants were recruited through community outreach using existing social networks, distribution of electronic flyers by community partners, and advertisement in local publications. Those interested contacted the study team who provided individualized links to the online survey or an invitation for every fourth person to participate in a “think aloud” interview via Zoom (Padilla & Leighton, 2017; Priede & Farrall, 2011). In interviews, a team member led participants through the scenarios and asked them to explain their reasoning for their chosen level of likelihood to participate with relevance to each scenario characteristic. Specific questions varied based on the participant’s decision and the relevant scenario. For example, if a participant chose that they “definitely would” participate in the relevant scenario, the interviewer first inquired about what led them to that decision. They followed that with probes regarding each factor in the scenario (i.e., “How did the use of study-specific consent influence your decision to participate?”). After participants fully explained their decision relative to each characteristic, they were probed about characteristic interactions (i.e., “Did it matter that that the researchers were White? Would it have been different if they had been African American?”). This process was repeated for each of the eight scenarios. The purpose of the interviews was to reveal what meaning participants ascribed to each characteristic as well as the interaction of characteristics in scenarios. While the survey data revealed discernable patterns in decision making, interviews afforded a view into the significance of characteristics and processes of decision making.

Participants received a $20 incentive for participation in the survey alone and $40 for participating in the “think aloud” interview. Interviews took approximately 20–30 min to complete. Surveys taken alone took an average of 10 min to complete.

Analysis

Quantitative Data.

For each of the eight scenarios separately the previously mentioned CART analyses were used within SPSS 28. CART methods recursively partition the entire sample (the parent node) into smaller subgroups (child nodes) based on the outcome variable. At each partition this method identifies the attribute that best separates data into subgroups related to the outcome, repeating the process until the sample is divided into homogenous groups and resulting in a classification tree. The benefit of this strategy, relative to other analytical techniques, is that it automatically yields combinations of attributes that statistically significantly separate the data based on the outcome variable, in this case willingness to participate in the research under given scenarios. For these analyses the minimum parent size was n = 10, the minimum child size was n = 5, and auto-pruning was used with the customary caliper of one standard error. The results included eight classification trees, each suggesting which variables individually and in combination were most important in participants’ decisions about study participation. The eight scenarios collectively served as an opportunity for replication and reliability regarding those variables’ consistent importance across scenarios. Indeed, each results tree yields measures of predictor importance, which is the relative value each variable has within a classification model.

Qualitative Data.

Interviews were audio recorded and professionally transcribed. We took a constructivist approach to the analysis with a focus on the meaning participants ascribed to the various factors in research scenarios as well as their meaningfulness in the decision to participate (or not). Our process was similar to the six phase analytical process of thematic analysis suggested by Braun and Clark (Braun & Clarke, 2021, 2022; Byrne, 2022). Coding was an iterative process following a period of data immersion. Codes and themes were data-driven, although the first pass of coding was done to label participant quotes by study attribute (form of consent, reason for research etc). From there, we used open coding to develop codes that were interpreted directly from participant statements. Two team members played an active role in analysis with one as primary coder. Throughout the coding process, the team discussed interpretation and emergent directions. Following coding, initial themes were interpreted from codes and used to develop a thematic map which was, in turn, used to continue to refine themes that cut across scenario factors. Initial themes were collapsed into larger conceptual categories. For example, concepts such as “shadiness/sketchiness” were collapsed with direct comments about ulterior motives (ex: use of DNA in the criminal justice system) to create the final theme of “hidden agendas.” Similarly, “sharing personal values with the goal of the research” and “supporting the black community” were both covered by the theme of “shared values.” Final interpretations of qualitative themes were accomplished with input from the entire team.

Informed consent was obtained from all subjects participating in this study. All methods were carried out in accordance with relevant guidelines and regulations and study procedures were reviewed and approved by the University of Wisconsin-Madison IRB (2019–1531).

Results

169 individuals participated in the online survey. Of these, 131 completed the survey on their own either on a computer, tablet, or cell phone. The remaining 38 participated in the “think aloud” interviews in which the survey was administered by a research team member. The sample had reasonable gender distribution and a mean age of 38 (range: 18–70). Surprisingly, as all participants identified as African American in the eligibility questionnaire (they would not have gained access to the survey if they had not), only 97% of participants self-identified as African American on the race/ethnicity items. Regarding race, 6 participants selected: Other – “Me” (1); White (1), American Indian (1), and no response (3). While recognizing the limitations of such definitions, we rely on the categories of ethnicity and race as used in the United Census in which Hispanic/Latino self-identification is recognized as an “ethnicity” and is, therefore, separated from “racial” categories (Marks & Jones, 2020). Characteristics of participants in the survey and the think aloud interviews (subset) are presented in Table 2. Participants in interviews were like those in the larger survey sample in most ways but did have somewhat higher incomes and education levels. It is possible that these participants were more likely to accept the invitation to participate in interviews than others.

Table 2.

Sample Characteristics (n = 169).

Demographics Survey Sample Think aloud interview subsample

Gender Woman 47% 47%
Man 52% 50%
Non-binary 1% 3%
Ethnicity Latino, Hispanic, Latinx 5% 5%
Race (select all that apply) African American 97%* 100%
Asian 1.8% -
Indian or Alaskan Native 3% 3%
White 16% 4%
Education No High School diploma or GED 3% -
High School diploma or GED 19% 14%
Some college, vocational school 37% 29%
Bachelor’s degree 24% 30%
Professional or post graduate degree (MA, MD, PhD) 17% 27%
Household Less than $25,000 23% 27%
Income $25,001-$40,000 22% 11%
$40,001-$55,000 13% 13%
$55,001-$65,000 9% 11%
$65,001-$75,000 9% 11%
$75,001-$100,000 8% 19%
More than $100,000 16% 8%
Location Madison 70% 62%
Milwaukee 23% 29%
Other 7% 9%
*

6 participants did not identify as African American in this question although all participants identified as such in the eligibility questionnaire. Regarding race, these participants selected: Other – “Me” (1); White (1), American Indian (1), and no response (3).

Quantitative Results

A slim majority (56%) of scenarios were found to be acceptable to participants (participants reported that they “probably would” or “definitely would” participate). Figure 2 presents a simple summary of quantitative data, percentage of scenarios which participants found acceptable (“probably would or “definitely would” participate) for each characteristic. The most dramatic differences are found regarding form of consent where a tiered form of consent (10.3%) was represented in acceptable scenarios about twice as much as broad consent (5.0%). There were less dramatic preferences for scenarios sponsored by universities rather than the government and those led solely by researchers who identified as African American. CART analysis confirmed that only form of consent was determined to drive decision making.

Figure 2.

Figure 2.

Percentage of acceptable scenarios in which each characteristic appeared (n = 169).

Without presenting the details of each of the eight CART analyses, we may consider the relative importance of each predictor variable summatively across all analyses. In seven of the eight analyses the most predictive variable was form of consent (it was the second most important predictor in the other analysis), making it far and away the most important predictor. Indeed, using a normed importance measure, d = form of consent averaged nearly three times the importance of the other measures (data use consent, 91.7; agency, 36.2; cure, 33.7; researcher race, 32.5). The bifurcation was between a specimen being used without consent vs. being destroyed or used with consent, typically creating subgroups more than a full standard deviation apart. The next most salient predictor in each analysis was evenly divided among the remaining three scenario characteristics. All analyses were repeated including demographic variables and previous research participation as eligible predictors, none of which altered the clear dominance of the consent variable in predicting participation.

Qualitative Results

Participants explained their decisions with reference to six themes we have termed, control, hidden agendas, comfort, familiarity, shared goals and competency. Most of these have both a negative and positive connotation (i.e., existing familiarity/lack of familiarity) and most were found across scenario factors. For example, participants were wary of hidden agendas that may be lurking in research scenarios in which there were white researchers as well as those using of broad consent. Two of these themes, comfort and control, were closely related and had to do with participants feelings of security (or lack) inspired by scenario attributes and reflected a relatively low level of abstraction (participants frequently used these specific words) but were used quite pervasively in interviews. There were also several themes that played into decision making that could be seen as adding or subtracting from participant feelings of comfort/control. Familiarity, knowledge of an institution or type of person added to positive decisions about research as did a perception of competency. Competency (regarding PIs) was seen as both scientific knowledge and cultural competency. The theme of shared goals was seen in reference to both the goal of the hypothetical research and goals related to the support of the Black community. Our only unique negative theme was hidden agendas. While in some ways hidden agendas could be seen as the negative of shared goals or control, it was also seen more broadly. This theme covered commonly expressed concerns that an unknown person or force may be at play in the scenario which would ultimately harm the participant with reference to the use of broad consent, institutional affiliation and race of the researchers. Each of these themes are discussed below with reference to research scenario attributes.

Form of Consent: Regarding the different forms of consent, the themes of control, comfort, and hidden agendas were expressed by participants in a strongly patterned way. In scenarios in which broad consent was used, participants expressed concerns about the lack of control of their DNA following the hypothetical study. For example,

But the main factor is my blood, you know, my biology being out there, and who knows what’s happening with it?

And,

Not knowing where my blood is going, where any of my genetic markers are going, that’s a little spooky.

For many, this went a step further to include references to malintent of involved parties and, subsequent, misuse of their DNA (hidden agendas). In other words, we found the themes of (lack of) control and hidden agendas often traveled together. For example, participants expressed concern that broad consent exposed them to harmful agendas of the criminal justice system or unethical scientists.

I would read the small print because, you know, that’s my DNA. I mean, is that tracing back to the police department or FBI? I mean, who’s overseeing these studies? … Like are you sharing it with third parties?

And,

But if I don’t know what else they’re doing with my blood… I don’t want them to just use it, sacrificing my blood to animals or some weird stuff like that.

Even when there was no specific fear of hidden agendas, participants equated a lack of control with a vague sense of suspicion (ex: being “shady”).

I’d want to know everything that my blood is going to be used for. I don’t want to be kept in the dark. That just sounds shady.

In contrast, the use of tiered consent or study specific consent was viewed as more positively affording a sense of control or comfort. Indeed, these words figured prominently in most quotes on the topic. For example, regarding tiered consent,

So then I have control of where my blood is going to and, you know, or the different studies that it’s going to be involved in. So that makes me feel a little bit more… I care about doing it.

And,

And then I don’t mind them being used for other studies, as long as somebody is just, you know, gives me a heads up. Hey, we’re going to send it over here or over there, because that makes me more comfortable.

Regarding study-specific consent, where their DNA would be destroyed following the hypothetical scenario, participants expressed similar ideas.

Because it says my blood will be destroyed. So once that test is over with, and the research is done, my blood is going to be, you know, destroyed, so it’s not going to go nowhere else. So I have more, you know, control of this study than all the rest.

And,

But, yeah, I got a little more open when I heard it was to cure a disease that affects everybody, and then the samples that I then provide will be destroyed. So that made me feel, like, a bit more secure and stuff.

Most interesting to our study team was that it was difficult to discern from participant responses whether they were considering study-specific or dynamic consent because they were so similar. The presence of tiered consent in scenarios made participants feel “comfort-able” even when their genetic material was to be stored for use in further studies.

Institutional Affiliation: Participant preferences for either Medical College of Wisconsin (in Milwaukee) or the University of Wisconsin-Madison were influenced by their level of familiarity with the institution in question. In general, participants in Madison viewed Medical College of Wisconsin as less desirable and less well known. For example,

Like, I feel like I know the school more and like trust the school more, yeah. I think that did feel better initially.

And,

I like the University of Wisconsin-Madison. I’m more familiar with that than the other places…

When the institution was the United States government, participants expressed considerably more concerns and noted both general fears of untrustworthiness along with specific abuses of trust such as the Tuskegee Syphilis Study and the case of Henrietta Lacks. In each of these examples, individuals in power did not share their full intent with participants or patients.

I don’t trust government, the American government anyway … You know, just the past history of doing a lot of, you know, shady, just sort of … things. A lot of the policies they’ve passed have affected how black people view medicine research today, so it’s just like, and they really haven’t done a lot to change that view. So I just wouldn’t care to be involved in the study.

Race of the Researchers:

The presence of White researchers in scenarios triggered neutral or negative responses, while African American researchers were met with positive assessments. Participants expressed familiarity with White researchers and health professionals, but some also interpreted their involvement in the study as an indication of potential hidden agendas. For example, in response to a scenario including a research goal of helping the African American community and two White researchers, one participant noted,

I definitely want something that’s going to help African Americans…I don’t necessarily believe that white folks, like, that’s their priority.

In contrast, African American researchers were seen as more trustworthy, competent and their research was viewed as a way to contribute to the shared goal of supporting the African American community. For example,

… if the results turn out to be something pretty impactful, it would be a good thing to have that credit go to some black scientists, black researchers because, do you know what I mean? So that’s why I would definitely go for that one, yeah.

And.

But to see somebody of color, you know, I guess I’m culturally competent when it comes to people of color, or black people, so I can relate to them better. I just don’t trust all white folks, and I’m just not sure, you know, what their agenda is sometimes. So it makes me feel better knowing that it’s two black people.

In research scenarios with both a White and an African American principal investigator, results were less clear, perhaps reflecting some ambivalence. Participants saw diversity in project leadership as either a plus in terms of the quality of the science (i.e., cultural competency) or a potential indication that the African American scientist is being used, as one participant put it, as a “sway tactic” or token.

…so it’s not just a white person that is on the research team. It’s also African American, and they can relate to, you know, the struggles we have as African Americans when it comes to these types of research.

And,

And this also brings me back to the current vaccine. Like they came with this vaccine, and they promoted, oh, there’s a black scientist who helped create it …But also, are they using that person as a prop?

Goal of the Research:

Qualitatively, participants expressed strong desires to participate in research that directly addressed a condition experienced by someone close to them. Some even found broad consent acceptable under these conditions although not to the level of significance in the quantitative analysis.

I’m going to say definitely would, and that’s because it is very important to cure the diseases of people around me, you know. They do matter more to me...

Importantly, research goals of “helping the African American community” or “someone close to me” were interpreted similarly by participants.

Well, if it’s going to like help cure disease that affects African Americans, that’s like, you know, impacts my family potentially, be beneficial to people I’m very close to. So that definitely is probably the biggest draw for me, the permission one too again.

Regarding research set to cure a disease or condition impacting all populations equally, participants were divided with some supporting this goal and others doubting its feasibility. For example,

I like the fact that it’s equally for all because I feel like that study might promote future studies to be done that way, to create for the greater good.

And,

Yeah, for that personally, I also have, like, a health background, so when I think of things, like, being affected people equally, I almost feel, like, that’s just not realistic. Like, I think people are affected different ways. So I think, for me, that was, like, the first card that I was, like, oh, I don’t know. I have to learn a little bit more about this.

Qualitative Interactions:

There were a few combinations of scenario characteristics that produced patterned responses in qualitative data. Participant feelings of vulnerability were associated with scenarios in which broad consent, the United States government and, to a lesser extent, White researchers appeared. Not surprisingly, when these appeared together in a single scenario it was judged as not acceptable. The use of broad consent by the government was especially viewed as a “deal breaker.” White researchers representing the government were specifically untrustworthy to the extent that some viewed this constellation of characteristics to prohibit participation even in scenarios in which they would, at least theoretically, maintain control over their DNA. For example,

I honestly don’t trust the U.S. Government. They’ve lied so many times about so many different studies and results…and then with them both being white, that’s another, with me being black, that’s another red flag for me. And then the other, I would honestly say, is the fact that they claim it would be destroyed. I can’t give you 100% consent that I trust that both of the white U.S. Government would actually destroy my blood after they say they will.

Conversely, some participants reported that a research goal of helping someone close to them overrode concerns about the potential misuse of biological specimens.

So if it’s somebody close to me, I definitely will want to participate most likely. So then without me knowing wouldn’t be as impactful, using my blood without me knowing, because as long as it’s being used for somebody that I know that’s close to me, it’s not as big a deal, you know.

Discussion

Qualitatively, our participants preferred research opportunities where they had control over the use of their DNA (tiered/dynamic consent; study specific consent), when there was an African American researcher (who might better understand their needs as well share their values), when the research goal was similar to their own goals, and when the affiliated institution had a positive reputation that was familiar to them. Each of these involved concepts that have been described elsewhere as components of trust and trustworthiness (Jamison et al., 2019; Passmore et al., 2020b; Twyman et al., 2008) and have been associated with greater willingness to participate in research in previous studies (Green-Harris et al., 2017; Passmore et al., 2016; Quinn et al., 2013).

Our findings uniquely add quantitative findings that clearly indicate that these attributes were not equally weighted in decision making. While participants ascribed meaning, both positive and negative, to all of the study attributes we offered in scenarios (form of consent, reason for research, institutional affiliation and race of the researcher), only form of consent was shown quantitatively to drive decision making about willingness to participate in research scenarios. In other words, the presence of broad consent in scenarios overrode all other factors in participant decision-making. Further, participants ascribed different meaning to the use of broad consent relative to study-specific or tiered consent. In particular, participants expressed significant concerns about losing control of their DNA which is not surprising given the history of research abuse and marginalization. In contrast, when participants maintained hypothetical control over their genetic material through study specific or tiered consent, participants felt control and, perhaps relatedly, a sense of comfort. Each of these contributed to a strong enough sense of trustworthiness for participants to consider participation in research. The close relationship between tiered and study consent is also evident in Figure 2. It is important to note that overall participants were willing to have their genetic material available for use in other, future studies (i.e., use of a biobank), as long as they were able to make decisions to govern the specific uses.

Currently, broad consent is the more common practice for various reasons. Certainly, it is the most convenient way to maximize the use of data. Other forms of consent are complicated and pose unique challenges. For example, tiered and dynamic forms of consent have been said to be potential threats to participant confidentiality (Petrini, 2010), may lead participants to accept the therapeutic misconception (Steinsbekk et al., 2013), and may place undue pressure on participants by offering too much choice (Ram, 2007). Moreover, there is some evidence that participants prefer the use of broad consent to other forms of consent. However, these assessments seem to be most relevant for those groups already well represented in research (N. A. Garrison et al., 2016; Simon et al., 2011).

Our finding indicate a need for a shift in consent patterns to account for issues of distrust or mistrust found among marginalized communities (Bogart et al., 2020; Corbie-Smith et al., 2002; Rajakumar et al., 2009; Scharff et al., 2010). It is clear that history, culture, politics and other contexts potentially create differences in participant views of science and research. Similar situations have been described with reference to participants recruited into biospecimen research from low- and middle-income countries (Nembaware et al., 2019; Tiffin, 2018; Tindana & de Vries, 2016). In Africa, for example, broad consent may not feasible due to the context of historical research abuse and the continued vulnerabilities (Tiffin, 2018). Moreover, such histories can shift the perception of what it means to participate in research. For example, Barsdorf and Wassenaar have shown that the meaning of “voluntariness” in research participation has been shaped in the specific context of South Africa (Barsdorf & Wassenaar, 2005).

Most importantly, our findings indicate that while “trustworthiness” may be driven by similar components (Jamison et al., 2019; Passmore et al., 2020b; Twyman et al., 2008), their meaning is uniquely connected to historical and current social contexts which must be supported in inclusive research. We cannot conclude on the acceptability of any approach, policy or procedure based on what works with any one segment of the population nor can we determine directions using the rubric of what best “benefits science.” As a community, we should all be sharply aware of the grievous ethical missteps using such a rubric has caused. Rather, our actions should reflect a recognition that science itself is shaped by a historical and current context (Buchanan et al., 2021; Henderson, 2022; Walsdorf et al., 2020) which should cause us to critically consider alternate approaches.

Conclusion

As trust in research and researchers is not randomly distributed in the population, practices such as the use of broad consent may equate to the exclusion of populations already bearing a disproportionate burden of illness in the form of health disparities. Exclusion which, in turn, contradicts our ethical obligation of justice to fairly distribute the benefits and burden of research. Our task to improve the inclusivity of research is to create studies that are welcoming to all (Gilmore-Bykovskyi et al., 2021; Griffith et al., 2020; Wilkins, 2018). Our success depends on our willingness to explore the range of participant perspectives and to build our studies accordingly. Increasing the trustworthiness of research and researchers is an important ultimate goal, albeit one that will require considerable cultural and structural shifts (Griffith et al., 2020; Wilkins, 2018). In the meantime, participant control of data, through limited consent processes, is an important asset in the absence of trust/trustworthiness of researchers. Protocols that maximize participant choice may ensure that research involving biological samples are created in ways to support, not block, diverse participation and reflect the shift toward a focus on the trustworthiness of science and scientists urged recently across medical science(Gilmore-Bykovskyi et al., 2021; Griffith et al., 2020; Wilkins, 2018).

Study Limitations

While there are several benefits of the use of the StoryDeck to access factors contributing to decision making, there are also drawbacks. Among these is that the exploration is deductively framed by our choice of hypothetical research attributes which may have resulted in the loss of important insights. The reader may be interested in previous uses of the StoryDeck regarding additional factors (Passmore et al., 2023; Passmore et al., 2020b). Overall, we have found that including more factors can quickly led to an unacceptable participant burden. In addition, there also were choices, such as the use of Zoom interviews, necessary due to public health restrictions at the time, but that may have created limitations for this study. It is possible that the use of zoom may have been discouraging to participants unfamiliar with the platform. This could explain why participants in interviews had higher education and income levels than the general survey population.

Best Practices

Those interested in the engagement of study participants from a range of backgrounds should be aware that this goal may require a shift from the traditional ways of doing research. Investigators should be open to the perspectives of all potential participants, especially those underrepresented in research, to ensure that there are no undue barriers placed to participation. Researchers should also be aware that potential participants assign meaning to aspects of studies such as the diversity to be found on research teams and their institutional affiliations. Participants may feel more welcome in studies in familiar settings that are oriented to the needs their needs. Participants also may be more motivated to participate in studies in which they feel that they have a stake in the outcome. Certainly, researchers should strongly consider the use of tiered or dynamic consent in studies using biobanks.

Research Agenda

This study points to interesting questions about how forms of consent may present barriers for research participants. This could be explored further with other populations who are also underrepresented in research. Additionally, “deeper dives” into several for the findings in this study are warranted. For example, through the current study, we have only glimpsed the meaning participants ascribe to the diversity and institutional affiliations research teams and our findings indicate considerable nuance.

Educational Implications

Many investigators are unsure about practical strategies to increase diversity in research participation in their own work. The findings from this study will be incorporated into trainings, workshops and other educational programs for investigators through our Just Research program at the University of Wisconsin, to promote awareness of inclusive research practices.

Acknowledgements and Funding

The project was supported by a grant from the National Human Genome Research Institute (R21 MD015130). This work also received support from the University of Wisconsin, Institute for Clinical and Translational Research (NCATS: UL1 TR002373), the School of Nursing as well as the Office of the Vice Chancellor for Research and Graduate Education with funding from the Wisconsin Alumni Research Foundation.

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Human Genome Research Institute, National Center for Advancing Translational Sciences, (grant number R21HG011503, UL1TR002373).

Biographies

Susan Racine Passmore is an Assistant Professor of Nursing at the University of Wisconsin-Madison. Her work focuses on engagement, recruitment science and research equity.

Abigail Gerbitz was a Master of Public Health student at the time that this work was completed. She is currently a Research Health Educator at the Medical College of Wisconsin.

Gregory R. Hancock is Professor and Director of the Quantitative Methodology: Measurement and Statistics program in the Department of Human Development and Quantitative Methodology at the University of Maryland, College Park, and Director of the Center for Integrated Latent Variable Research (CILVR). His research interests include structural equation modeling and latent growth models, the use of latent variables in (quasi) experimental design, and power analysis.

Laura Evans is a doctoral student in the Department of Human Development and Family Studies, University of Wisconsin-Madison. She is interested in biracial and multiracial studies and identity development in children.

Gina Green-Harris is Director, Center for Community Engagement and Health Partnerships, School of Medicine, University of Wisconsin-Madison. She has expertise in the areas of health equity, diversity and inclusion, cultural competency, leadership development, and research.

Dorothy Farrar Edwards is a professor in the School of Education with appointments in the departments of Medicine and Neurology at the School of Medicine and Public Health. She leads the Outreach, Recruitment & Engagement Core and is coleader for the Inclusion of Under-Represented Groups Core at the Wisconsin ADRC. She serves as director of the Collaborative Center for Health Equity with the University of Wisconsin Institute for Clinical and Translational Research.

Tyson Jackson is Senior Community Outreach Coordinator with the Collaborative Center for Health Equity and the All of Us UW Research Program. He has considerable experience establishing and maintaining multiple community-academic partnerships.

Stephen B. Thomas is Professor in the department of Health Policy and Management and Director, Center for Health Equity. He is one of the nation’s leading scholars in the effort to eliminate racial and ethnic health disparities and has applied his expertise to address a variety of conditions from which Black communities and other communities of color generally face far poorer outcomes, including cardiovascular disease, diabetes, obesity and HIV/AIDS.

References

  1. Barsdorf NW, & Wassenaar DR (2005). Racial differences in public perceptions of voluntariness of medical research participants in South Africa. Social Science & Medicine (1982), 60(5), 1087–1098. 10.1016/j.socscimed.2004.06.039 [DOI] [PubMed] [Google Scholar]
  2. Boden-Albala B, Waddy SP, Appleton N, Kuczynski H, Nangle E, & Parikh NS (2021). Recruitment, inclusion, and diversity in clinical trials. In The science of health disparities research (pp. 413–428). John Wiley & Sons, Ltd. 10.1002/9781119374855.ch24 [DOI] [Google Scholar]
  3. Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, Lawrence SJ, Thomas D, & Kellman S. (2020). COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes, 86(2), 200–207. 10.1097/QAI.0000000000002570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Braun V, & Clarke V. (2021). Can I use TA? Should I use TA? Should I not use TA? Comparing reflexive thematic analysis and other pattern-based qualitative analytic approaches. Counselling and Psychotherapy Research, 21(1), 37–47. 10.1002/capr.12360 [DOI] [Google Scholar]
  5. Braun V, & Clarke V. (2022). Conceptual and design thinking for thematic analysis. Qualitative Psychology, 9(1), 3–26. 10.1037/qup0000196 [DOI] [Google Scholar]
  6. Buchanan NT, Perez M, Prinstein MJ, & Thurston IB (2021). Upending racism in psychological science: Strategies to change how science is conducted, reported, reviewed, and disseminated. American Psychologist, 76(7), 1097–1112. 10.1037/amp0000905 [DOI] [PubMed] [Google Scholar]
  7. Byrne D. (2022). A worked example of Braun and Clarke’s approach to reflexive thematic analysis. Quality & Quantity, 56(3), 1391–1412. 10.1007/s11135-021-01182-y [DOI] [Google Scholar]
  8. Corbie-Smith G, Thomas SB, & St George DMM (2002). Distrust, race, and research. Archives of Internal Medicine, 162(21), 2458–2463. 10.1001/archinte.162.21.2458 [DOI] [PubMed] [Google Scholar]
  9. D’Abramo F, Schildmann J, & Vollmann J. (2015). Research participants’ perceptions and views on consent for biobank research: A review of empirical data and ethical analysis. BMC Medical Ethics, 16(1), 60. 10.1186/s12910-015-0053-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davis RE, Caldwell CH, Couper MP, Janz NK, Alexander GL, Greene SM, Zhang N, & Resnicow K. (2013). Ethnic identity, questionnaire content, and the dilemma of race matching in surveys of African Americans by African American interviewers. Field Methods, 25(2), 142–161. 10.1177/1525822X12449709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Echeverri M, Anderson D, Nápoles AM, Haas JM, Johnson ME, & Serrano FSA (2018). Cancer health literacy and willingness to participate in cancer research and donate bio-specimens. International Journal of Environmental Research and Public Health, 15(10), Article 10. 10.3390/ijerph15102091 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fatumo S, Chikowore T, Choudhury A, Ayub M, Martin A, & Kuchenbaecker K. (2022). A roadmap to increase diversity in genomic studies. Nature Medicine, 28(2), 243–250. 10.1038/s41591-021-01672-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Frierson GM, Pinto BM, Denman DC, Leon PA, & Jaffe AD (2019). Bridging the Gap: Racial concordance as a strategy to increase African American participation in breast cancer research. Journal of Health Psychology, 24(11), 1548–1561. 10.1177/1359105317740736 [DOI] [PubMed] [Google Scholar]
  14. Fryer CS, Passmore SR, Maietta RC, Petruzzelli J, Casper E, Brown NA, Butler J, Garza MA, Thomas SB, & Quinn SC (2015). The Symbolic Value and Limitations of Racial Concordance in Minority Research Engagement. Qualitative Health Research, 26(6), 830–841. 10.1177/1049732315575708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Garrison N. (2013). Genomic justice for native Americans: Impact of the Havasupai case on genetic research. Science, Technology, & Human Values, 38(2), 201–223. 10.1177/0162243912470009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Garrison NA, Sathe NA, Antommaria AHM, Holm IA, Sanderson SC, Smith ME, McPheeters ML, & Clayton EW (2016). A systematic literature review of individuals’ perspectives on broad consent and data sharing in the United States. Genetics in Medicine, 18(7), 663–671. 10.1038/gim.2015.138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gilmore-Bykovskyi A, Jackson JD, & Wilkins CH (2021). The urgency of justice in research: Beyond COVID-19. Trends in Molecular Medicine, 27(2), 97–100. 10.1016/j.molmed.2020.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Green SB (1991). How many subjects does it take to do A regression analysis. Multivariate Behavioral Research, 26(3), 499–510. 10.1207/s15327906mbr2603_7 [DOI] [PubMed] [Google Scholar]
  19. Green-Harris G, Koscik RL, Houston S, Norris N, Mahoney J, Sager MA, Johnson SC, & Edwards DF (2017). Using asset-based community involvement to address health disparities and increase African American participation in AD research: Experiences from the Wisconsin Alzheimer’s institute. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 13(7), P897–P898. 10.1016/j.jalz.2017.07.308 [DOI] [Google Scholar]
  20. Griffith DM, Jaeger EC, Bergner EM, Stallings S, & Wilkins CH (2020). Determinants of trustworthiness to conduct medical research: Findings from focus groups conducted with racially and ethnically diverse adults. Journal of General Internal Medicine, 35(10), 2969–2975. 10.1007/s11606-020-05868-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Guillemin M, Barnard E, Allen A, Stewart P, Walker H, Rosenthal D, & Gillam L. (2018). Do research participants trust researchers or their institution? Journal of Empirical Research on Human Research Ethics, 13(3), 285–294. 10.1177/1556264618763253 [DOI] [PubMed] [Google Scholar]
  22. Henderson D. (2022). Toward a new epistemology for medical science. Family Medicine, 54(6), 427–430. 10.22454/FamMed.2022.472998 [DOI] [PubMed] [Google Scholar]
  23. Jamison AM, Quinn SC, & Freimuth VS (2019). You don’t trust a government vaccine”: Narratives of institutional trust and influenza vaccination among African American and white adults. Social Science & Medicine, 221(1), 87–94. 10.1016/j.socscimed.2018.12.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Knepper TC, & McLeod HL (2018). When will clinical trials finally reflect diversity? Nature, 557(7704), 157–159. 10.1038/d41586-018-05049-5 [DOI] [PubMed] [Google Scholar]
  25. Lemke AA, Halverson C, & Ross LF (2012). Biobank participation and returning research results: Perspectives from a deliberative engagement in south Side Chicago. American Journal of Medical Genetics Part A, 158(5), 1029–1037. 10.1002/ajmg.a.34414 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Levkoff S, & Sanchez H. (2003). Lessons learned about minority recruitment and retention from the centers on minority aging and health promotion. The Gerontologist, 43(1), 18–26. 10.1093/geront/43.1.18 [DOI] [PubMed] [Google Scholar]
  27. Marks R, & Jones N. (2020). Collecting and tabulating ethnicity and race responses in the 2020 census. United States Census Bureau. [Google Scholar]
  28. Mills MC, & Rahal C. (2020). The GWAS diversity monitor tracks diversity by disease in real time. Nature Genetics, 52(3), Article 3. 10.1038/s41588-020-0580-y [DOI] [PubMed] [Google Scholar]
  29. Moulton H, Moulton B, Lahey T, & Elwyn G. (2020). Can consent to participate in clinical research involve shared decision making? AMA Journal of Ethics, 22(5), 365–371. 10.1001/amajethics.2020.365 [DOI] [PubMed] [Google Scholar]
  30. Nembaware V, Johnston K, Diallo AA, Kotze MJ, Matimba A, Moodley K, Tangwa GB, Torrorey-Sawe R, & Tiffin N. (2019). A framework for tiered informed consent for health genomic research in Africa. Nature Genetics, 51(11), 1566–1571. 10.1038/s41588-019-0520-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Niranjan SJ, Martin MY, Fouad MN, Vickers SM, Wenzel J, Cook ED, Konety BR, & Durant RW (2019). Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials. Journal of Clinical Oncology, 37(27_suppl), 152–152. 10.1200/JCO.2019.37.27_suppl.152 [DOI] [PubMed] [Google Scholar]
  32. Oh SS, Galanter J, Thakur N, Pino-Yanes M, Barcelo NE, White MJ, Bruin D. M. d., Greenblatt RM, Bibbins-Domingo K, Wu AHB, Borrell LN, Gunter C, Powe NR, & Burchard EG (2015). Diversity in clinical and biomedical research: A promise yet to be fulfilled. PLOS Medicine, 12(12), e1001918. 10.1371/journal.pmed.1001918 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Padilla J-L, & Leighton JP (2017). Cognitive interviewing and think aloud methods. In Zumbo BD, & Hubley AM (Eds.), Understanding and investigating response processes in validation research (pp. 211–228). Springer International Publishing. 10.1007/978-3-319-56129-5_12 [DOI] [Google Scholar]
  34. Passmore SR, Fryer CS, Butler J, Garza MA, Thomas SB, & Quinn SC (2016). Building a “Deep Fund of Good Will”: Reframing research engagement. Journal of Health Care for the Poor and Underserved, 27(2), 722–740. 10.1353/hpu.2016.0070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Passmore SR, Jamison AM, Abdelwadoud M, Rogers TB, Wiggan M, Mullins DC, & Thomas SB (2020a). Use of a qualitative story deck to create scenarios and uncover factors associated with African American participation in genomics research. Field Methods, 33(2), 159–174. 10.1177/1525822X20982089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Passmore SR, Jamison AM, Hancock GR, Abdelwadoud M, Mullins CD, Rogers TB, & Thomas SB (2020b). “I’m a little more trusting”: Components of trustworthiness in the decision to participate in genomics research for African Americans. Public Health Genomics, 22(5–6), 215–226. 10.1159/000505271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Passmore SR, Kisicki A, Gilmore-Bykovskyi A, Green-Harris G, & Edwards DF (2021). There’s not much we can do…” researcher-level barriers to the inclusion of underrepresented participants in translational research. Journal of Clinical and Translational Science, 6(1), 1–9. 10.1017/cts.2021.876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Passmore SR, Longhurst C, Gerbitz A, Green-Harris G, Norris N, & Edwards DF (2023). “I want to know everything … ”: The return of research results and the importance of transparency in the acceptability of lumbar punctures for African American older adults. Journal of Alzheimer’s Disease, 95(2), 663–675. 10.3233/JAD-230275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Petrini C. (2010). “Broad” consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose. Social Science & Medicine, 70(2), 217–220. 10.1016/j.socscimed.2009.10.004 [DOI] [PubMed] [Google Scholar]
  40. Priede C, & Farrall S. (2011). Comparing results from different styles of cognitive interviewing: ‘verbal probing’ vs. ‘thinking aloud.’. International Journal of Social Research Methodology, 14(4), 271–287. 10.1080/13645579.2010.523187 [DOI] [Google Scholar]
  41. Quinn SC, Kass NE, & Thomas SB (2013). Building trust for engagement of minorities in human subjects research: Is the glass half full, half empty, or the wrong size? American Journal of Public Health, 103(12), 2119–2121. 10.2105/AJPH.2013.301685 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rajakumar K, Thomas SB, Musa D, Almario D, & Garza MA (2009). Racial differences in parents’ distrust of medicine and research. Archives of Pediatrics & Adolescent Medicine, 163(2), 108–114. 10.1001/archpediatrics.2008.521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ram N. (2007). Tiered consent and the tyranny of choice. Jurimetrics, 48(3), 253. [Google Scholar]
  44. Reverby SM (2010). Invoking “Tuskegee”: Problems in health disparities, genetic assumptions, and history. Journal of Health Care for the Poor and Underserved, 21(3), 26–34. 10.1353/hpu.0.0354 [DOI] [PubMed] [Google Scholar]
  45. Scharff DP, Mathews KJ, Jackson P, Hoffsuemmer J, Martin E, & Edwards D. (2010). More than Tuskegee: Understanding mistrust about research participation. Journal of Health Care for the Poor and Underserved, 21(3), 879–897. 10.1353/hpu.0.0323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Simon CM, L’Heureux J, Murray JC, Winokur P, Weiner G, Newbury E, Shinkunas L, & Zimmerman B. (2011). Active choice but not too active: Public perspectives on biobank consent models. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 13(9), 821–831. 10.1097/GIM.0b013e31821d2f88 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Steinsbekk KS, Kåre Myskja B, & Solberg B. (2013). Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem? European Journal of Human Genetics, 21(9), Article 9. 10.1038/ejhg.2012.282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tiffin N. (2018). Tiered informed consent: Respecting autonomy, agency and individuality in Africa. BMJ Global Health, 3(6), e001249. 10.1136/bmjgh-2018-001249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tindana P, & de Vries J. (2016). Broad consent for genomic research and biobanking: Perspectives from low- and middle-income countries. Annual Review of Genomics and Human Genetics, 17(1), 375–393. 10.1146/annurev-genom-083115-022456 [DOI] [PubMed] [Google Scholar]
  50. Trinidad SB, Fullerton SM, Bares JM, Jarvik GP, Larson EB, & Burke W. (2010). Genomic research and wide data sharing: Views of prospective participants. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 12(8), 486–495. 10.1097/GIM.0b013e3181e38f9e [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Twyman M, Harvey N, & Harries C. (2008). Trust in motives, trust in competence: Separate factors determining the effectiveness of risk communication. Judgment and Decision Making, 3(1), 111. 10.1017/S1930297500000218 [DOI] [Google Scholar]
  52. Walsdorf AA, Jordan LS, McGeorge CR, & Caughy MO (2020). White supremacy and the web of family science: Implications of the missing spider. Journal of Family Theory & Review, 12(1), 64–79. 10.1111/jftr.12364 [DOI] [Google Scholar]
  53. Wilkins CH (2018). Effective engagement requires trust and being trustworthy. Medical Care, 56(10 Suppl 1), S6–S8. 10.1097/MLR.0000000000000953 [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES